Medtronic Evolut R System Recalled for Potential Valve Leaflet Damage
Medtronic is recalling Evolut R System transcatheter aortic valves due to a potential risk of leaflet damage during post-implant balloon dilatation.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk-of-harm product (medical device) where injury has not yet been reported, fitting the 'High' severity criteria.
Plain-English summary
Medtronic Heart Valves Division is recalling the Evolut (TM) R System, a transcatheter aortic valve (TAV) device, due to a potential for leaflet damage. The recall affects specific model numbers including EVOLUTR-23, EVOLUTR-26, EVOLUTR-29, and EVOLUTR-34, along with their associated variants. The hazard is identified as the potential for damage to the valve leaflets when a post-implant balloon dilatation (PID) procedure is performed.
The recall covers 172,851 units that were distributed worldwide, including nationwide distribution in the United States and in numerous other countries such as Panama, Denmark, Austria, Germany, Finland, Sweden, Colombia, India, Mexico, Brazil, Spain, the United Kingdom, Australia, Ireland, Italy, Argentina, Japan, Poland, the Russian Federation, Hungary, Kazakhstan, Luxembourg, Portugal, Norway, Egypt, and Saudi Arabia. The agency has classified this recall as Class II.
Healthcare providers and patients should be aware of this potential risk. The source text does not specify specific consumer actions beyond the identification of the hazard and the affected units. Users should refer to the manufacturer's instructions and consult with their medical provider regarding the use of the device and the performance of post-implant balloon dilatation.
The recalled product
- Product
- Evolut (TM) R System. With the following model numbers: a. EVOLUTR-23, Labeled as VLV EVOLUTR-23 VT IR 6L COMM OUS, VLV EVOLUTR-23 TAV EVOLUT R CE 29L MX, VLV EVOLUTR-23 TAV CE AU 2Y MX, VLV EVOLUTR-23 TAV JPN MX, VLV EVOLUTR-23 GREY 29L COMM OUS, VLV EVOLUTR-23 TAV EVOLUT
- Manufacturer
- Medtronic Heart Valves Division
- Category
- Medical Device — Cardiovascular
- Affected units
- 172,851
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Medtronic Heart Valves Division under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Medtronic Heart Valves Division
See all →- SevereMedtronic Harmony Delivery Catheter System Distal Tip Detachment Risk
FDA (Devices) · 2026-07-08
- HighMedtronic CoreValve Evolut PRO Delivery Catheter Actuator Separation Recall
FDA (Devices) · 2021-07-14
- HighMedtronic CoreValve Evolut R Delivery Catheter System Recalled for Actuator Separation
FDA (Devices) · 2021-07-14
- HighCoreValve Evolut PRO PLUS Delivery Catheter Systems recalled for actuator separation
FDA (Devices) · 2021-07-14
- HighMedtronic Evolut PRO System Recalled for Potential Valve Leaflet Damage
FDA (Devices) · 2020-12-16
Same hazard · device defect
See all →- HighBoston Scientific ENROUTE Transcarotid Neuroprotection System Recall for Tip Separation
FDA (Devices) · 2026-08-26
- HighMicrovention Recalls Bobby Balloon Guide Catheters Due to Pinhole Defects
FDA (Devices) · 2026-08-19
- SevereMedtronic Perfusion Systems Recalls EOPA Elongated One-Piece Arterial Cannula Model 77722
FDA (Devices) · 2026-08-05
- SevereABIOMED Impella CP Introducer Kit 14 Fr potentially defective sheath
FDA (Devices) · 2026-07-22
- SevereAbiomed Impella CP Smart Assist Set Heart Pump Introducer Sheath Leakage
FDA (Devices) · 2026-07-22